Fintech PR
$10 million Artificial Intelligence Mathematical Olympiad Prize appoints advisory committee members
Fields Medallists Timothy Gowers and Terence Tao appointed to the Advisory Committee for the Artificial Intelligence Mathematical Olympiad Prize, alongside Po-Shen Loh, Dan Roberts and Geoff Smith.
LONDON, Feb. 7, 2024 /PRNewswire/ — XTX Markets’ newly created Artificial Intelligence Mathematical Olympiad Prize (‘AIMO Prize’) is a $10mn challenge fund designed to spur the creation of a publicly shared AI model capable of winning a gold medal in the International Mathematical Olympiad (IMO).
XTX Markets is delighted to be joined by a group of prominent mathematicians, and AI and machine learning specialists. The group includes Timothy Gowers and Terence Tao, both winners of the Fields Medal, one of the most prestigious awards in mathematics.
Alongside them are Po-Shen Loh, the former coach of the US IMO Team; Dan Roberts, an AI researcher at Sequoia Capital and MIT and a published expert in machine learning; and Geoff Smith, the former President of the IMO.
The AIMO Advisory Committee will support the development of the AIMO Prize, including advising on appropriate protocols and technical aspects, and designing the various competitions and prizes.
Terence Tao, Fields Medallist and Professor of Mathematics at UCLA, commented:
“Despite recent advances, using AI to solve, or at least assist with solving, advanced mathematical problems remains an incredibly complicated and multifaceted challenge. It will be important to experiment with multiple approaches to this goal, and to benchmark the performance of each of them.
The AIMO Prize promises to provide at least one such set of benchmarks which will help compare different AI problem solving strategies at a technical level, in a manner that will be accessible and appealing to the broader public.”
Timothy Gowers, Fields Medallist and Professor of Combinatorics at the Collège de France, commented:
“Machine learning methods have had spectacular success in several domains, but their performance on tasks that involve multi-step reasoning still lags behind. For this reason, solving advanced mathematics problems has been increasingly recognised as a major frontier for AI, the passing of which has the potential to open up a new wave of important applications. The AIMO prize will play a valuable role by stimulating research in this direction.
It is particularly welcome that the prizes are for publicly available research, as this will lead to faster and more efficient progress.”
There will be a grand prize of $5mn for the first publicly shared AI model to enter an AIMO approved competition and perform at a standard equivalent to a gold medal in the IMO. There will also be a series of progress prizes, totalling up to $5mn, for publicly shared AI models that achieve key milestones towards the grand prize.
The first AIMO approved competitions will open to participants in early 2024. There will be a presentation of progress held in Bath, England in July 2024, as part of the 65th IMO. More information on the progress prizes will be shared shortly.
Eoghan Flanagan, Director of the AIMO Prize, commented:
“We are delighted to welcome such esteemed members of the mathematical community to the advisory committee of the AIMO Prize. I look forward to working with them on developing and growing the Prize.”
For more information and updates on the AIMO Prize visit: https://aimoprize.com/
Advisory Committee member profiles:
Timothy Gowers
After winning a gold medal in the IMO in 1981, Timothy studied mathematics at Trinity College, Cambridge, where he did his PhD and was then a research fellow. After a period at University College London, he returned to Trinity, first as a lecturer and then as the Rouse Ball Professor of Mathematics. From 2009-2020 he was a Royal Society Research Professor, and since October 2020 has been Professor of Combinatorics at the Collège de France. He discovered the first quantitative proof of Szemerédi’s theorem and has subsequently worked in additive combinatorics, for which he was awarded a Fields Medal in 1998. In recent years, he has worked on automatic theorem proving and currently heads a research group in that field, concentrating on symbolic methods.
Po-Shen Loh
Po-Shen is a mathematics professor at Carnegie Mellon University, and a social entrepreneur who uses combinatorics and game theory to invent solutions ranging from education to pandemic control. He was an IMO silver medallist in his youth and then served a decade-long term as the Coach of the USA IMO Team, during which the team ranked #1 in the world four times. His lectures and events take him all over the world, reaching over 10,000 people in person and millions on YouTube each year. He received the United States Presidential Early Career Award for Scientists and Engineers, and is a Hertz Fellow.
Dan Roberts
Dan is an AI Fellow at Sequoia Capital and a researcher at MIT. Prior to joining Sequoia in 2023, he co-founded Diffeo, an AI company acquired by Salesforce, and was a research scientist at Facebook AI Research. As an AI researcher, he co-authored the book “The Principles of Deep Learning Theory,” published by Cambridge University Press. He was a postdoc at the Institute for Advanced Study at Princeton, completed a PhD in theoretical physics from MIT funded by a Hertz Fellowship, and studied in the UK as a Marshall Scholar.
Geoff Smith
Geoff Smith MBE is an activist in the mathematics olympiad community and has been involved in mathematics enrichment since 1990 and mathematics competitions since 1999. He was the elected President of the IMO between 2014 and 2022. He is the Chair of the United Kingdom Mathematics Trust and he was instrumental in setting up the European Girls’ Mathematical Olympiad in 2012, an event which now prospers under female governance. His academic career started in group theory, but later widened to include geometry and contributions to papers in the life sciences and social science. He is also an honorary reader in mathematics at the University of Bath.
Terence Tao
Terence Tao was born in Adelaide, Australia in 1975. He participated in three IMOs, culminating in a gold medal in 1987. He is a professor of mathematics at UCLA, having completed his PhD under Elias Stein at Princeton in 1996. His areas of research include harmonic analysis, PDE, combinatorics, and number theory. He has received a number of awards, including the Salem Prize in 2000, the Fields Medal in 2006, the MacArthur Fellowship in 2007, the Crafoord prize in 2012 and the Breakthrough Prize in Mathematics in 2015. Terence also holds the James and Carol Collins chair in mathematics at UCLA, is a fellow of several national academies and also serves on the President’s Council of Advisors on Science and Technology.
About XTX Markets:
XTX Markets is a leading financial technology firm which partners with counterparties, exchanges and e-trading venues globally to provide liquidity in the Equity, FX, Fixed Income and Commodity markets. XTX has over 200 employees based in London, Paris, New York, Mumbai, Yerevan and Singapore. XTX is consistently a top 5 liquidity provider globally in FX (Euromoney 2018-present) and is also the largest European equities (systematic internaliser) liquidity provider (Rosenblatt FY: 2020-2023).
The company’s corporate philanthropy focuses on STEM education and maximum impact giving (alongside an employee matching programme). Since 2017, XTX has donated over £100mn to charities and good causes, establishing it as a major donor in the UK and globally.
In a changing world XTX Markets is at the forefront of making financial markets fairer and more efficient for all.
View original content:https://www.prnewswire.co.uk/news-releases/10-million-artificial-intelligence-mathematical-olympiad-prize-appoints-advisory-committee-members-302055014.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News7 days ago
Money20/20 Asia 2024: Days Two Roundup
-
Latest News4 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News7 days ago
Stripe Unveils Unbundled Payments Strategy in Fintech Pivot
-
Latest News3 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News7 days ago
Zafin Unveils Strategic Leadership Transition in Canadian SaaS Fintech
-
Latest News6 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News6 days ago
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%